In Argentina, transgender women (TW) have the highest HIV prevalence (34%) among key populations, reporting challenges in adherence to antiretroviral therapy (ART) and HIV care. Physician-delivered motivational interviewing (MI) was examined for its impact on HIV-related outcomes. Multilevel models found an increase in patient–provider communication, self-reported ART adherence, and HIV-related outcomes over 24 months in 41 TW re-engaged in HIV care. About one-third (37%) of participants were retained in care at 24 months, and 55% achieved viral suppression at follow-up. Data supporting a link between MI and these improvements are inconclusive, and targeted interventions are needed in this population.
ChakrapaniV, WillieTC, ShunmugamM, et al.Syndemic classes, stigma, and sexual risk among transgender women in India. AIDS Behav, 2019; 23(6):1518–1529; doi: 10.1007/s10461-018-2373-1
5.
MimiagaMJ, HughtoJMW, BielloKB, et al.Longitudinal analysis of syndemic psychosocial problems predicting HIV risk behavior among a multicity prospective cohort of sexually active young transgender women in the United States. J Acquir Immune Defic Syndr, 2019; 81(2):184–192; doi: 10.1097/qai.0000000000002009
6.
BagusoGN, GayCL, LeeKA. Medication adherence among transgender women living with HIV. AIDS Care, 2016; 28(8):976–981; doi: 10.1080/09540121.2016.1146401
7.
WiewelEW, TorianLV, MerchantP, et al.HIV diagnoses and care among transgender persons and comparison with men who have sex with men: New York City, 2006-2011. Am J Public Health, 2016; 106(3):497–502; doi: 10.2105/ajph.2015.302974
8.
PapaliniC, LagiF, SchiaroliE, et al.Transgender people living with HIV: Characteristics and comparison to homosexual and heterosexual cisgender patients in two Italian teaching hospitals. Int J STD AIDS, 2021; 32(2):194–198; doi: 10.1177/0956462420950573
9.
RaduskyPD, AristeguiI, MandellLN, et al.Examining factors associated with gender identity among individuals disengaged from HIV care in Argentina. Int J Behav Med, 2022; 29(1):69–77; doi: 10.1007/s12529-021-09998-6
10.
SocíasME, MarshallBD, ArísteguiI, et al.Factors associated with healthcare avoidance among transgender women in Argentina. Int J Equity Health, 2014; 13(1):81; doi: 10.1186/s12939-014-0081-7
11.
GoldsteinZG. Overview of factors associated with hiv viral load suppression in transgender women. J Appl Lab Med, 2021; 6(1):257–263; doi: 10.1093/jalm/jfaa210
12.
MizunoY, FrazierEL, HuangP, SkarbinskiJ. Characteristics of transgender women living with HIV receiving medical care in the United States. LGBT Health, 2015; 2(3):228–234; doi: 10.1089/lgbt.2014.0099
13.
CrosbyRA, SalazarLF, HillBJ. Correlates of not using antiretroviral therapy among transwomen living with HIV: The unique role of personal competence. Transgend Health, 2018; 3(1):141–146; doi: 10.1089/trgh.2018.0006
14.
SeveliusJM, CarricoA, JohnsonMO. Antiretroviral therapy adherence among transgender women living with HIV. J Assoc Nurses AIDS Care, 2010; 21(3):256–264; doi: 10.1016/j.jana.2010.01.005
15.
SweeneySM, VanablePA. The association of HIV-related stigma to HIV medication adherence: A systematic review and synthesis of the literature. AIDS Behav, 2016; 20(1):29–50; doi: 10.1007/s10461-015-1164-1
16.
SuedO, CassettiI, CecchiniD, et al.Physician-delivered motivational interviewing to improve adherence and retention in care among challenging HIV-infected patients in Argentina (COPA2): study protocol for a cluster randomized controlled trial. Trials, 2018; 19(1):396; doi: 10.1186/s13063-018-2758-5
EkstrandML, ChandyS, HeylenE, et al.Developing useful highly active antiretroviral therapy adherence measures for India: The Prerana study. J Acquir Immune Defic Syndr, 2010; 53(3):415–416; doi: 10.1097/QAI.0b013e3181ba3e4e
19.
SeveliusJ, ChakravartyD, NeilandsTB, et al.HRSA SPNS Transgender Women of Color Study Group. Evidence for the model of gender affirmation: The role of gender affirmation and healthcare empowerment in viral suppression among transgender women of color living with HIV. AIDS Behav, 2021; 25(Suppl 1):64–71; doi: 10.1007/s10461-019-02544-2
20.
JohnsonMO, ChesneyMA, GoldsteinRB, et al.NIMH Healthy Living Project Team. Positive provider interactions, adherence self-efficacy, and adherence to antiretroviral medications among HIV-infected adults: A mediation model. AIDS Patient Care STDS, 2006; 20(4):258–268; doi: 10.1089/apc.2006.20.258
21.
RaduskyPD, ZalazarV, CardozoN, et al.Reduction of gender identity stigma and improvements in mental health among transgender women initiating HIV treatment in a trans-sensitive clinic in Argentina. Transgend Health, 2020; 5(4):216–224; doi: 10.1089/trgh.2020.0005
22.
Lacombe-DuncanA, BauerGR, LogieCH, et al.The HIV care cascade among transgender women with HIV in Canada: A mixed-methods study. AIDS Patient Care STDS, 2019; 33(7):308–322; doi: 10.1089/apc.2019.0013
23.
ZalazarV, AristeguiI, SocíasME, et al.Ethics and the treatment as prevention strategy among transgender women living with HIV in Argentina. Cult Health Sex, 2021; 23(5):674–689; doi: 10.1080/13691058.2020.1720821
24.
ChenW-T, ShiuC, YangJP, et al.A structural equation model of patient-healthcare provider relationships and HIV-infected patient outcomes in Chinese populations. AIDS Care, 2018; 30(3):383–390; doi: 10.1080/09540121.2017.1380778
25.
BocktingW, MacCrateC, IsraelH, et al.Engagment and retention in HIV care for transgender women: Perspectives of medical and social service providers in New York City. AIDS Patient Care STDS, 2020; 34(1):16–26; doi: 10.1089/apc.2019.0067
